CClinicalTrials.gg
CompletedNCT05214703Updated Jan 31, 2022

The Effect of Cold Therapy on Pain and Anxiety During the Implanted Port Catheter Removal

An interventional study of cold therapy application in Pain and Anxiety, sponsored by Yuksek Ihtisas University. Completed at 1 site in Turkey. Open to participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-01-31.

Sponsored by Yuksek Ihtisas University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 3 years 11 months after the study started (first participant enrolled Feb 2018, registered Jan 2022).
Phase
Not applicable
Study type
Interventional
Enrollment
112
Allocation
Non-randomized
Ages
18 Years to 65 Years
Sex
All
01

Study summary

This study was conducted as a quasi-experimental study to examine the effect of cold therapy on pain and anxiety during venous port catheter removal.

Read the detailed description

Pain and anxiety experienced during diagnosis and treatment in cancer patients affect the physical, psychological, and interpersonal well-being of individuals and affect their lives in all aspects. Nurses play a very important role in pain control. Pain control is very important in terms of ensuring the comfort of patients and increasing their quality of life. In order to provide this control; nurses can use non-pharmacological treatment methods that they can apply independently in pain management. Patients experience procedural pain during insertion and removal of an implantable port catheter, which is one of the painful invasive procedures that are placed under the skin with a small incision, and insertion of a needle into the port catheter. When the literature is examined, it is seen that there are a limited number of studies in which non-pharmacological methods are used in the control of pain and anxiety related to the implantable venous port catheter procedure, and in these studies, distraction, music therapy, and inhaler aromatherapy. However, no study was found in which cold application was used to reduce the pain and anxiety caused by the removal of the port catheter in cancer patients. Therefore, the aim of the study is to evaluate the effectiveness of cold application on procedural pain and anxiety associated with port catheter removal, which is frequently used in the treatment of cancer patients. Cold therapy as an independent nursing intervention in reducing anxiety and pain management during port catheter removal in cancer/oncology patients; can be transferred to clinical practice by oncology nurses, improving the quality of nursing care, ensuring patient safety, and increasing patient satisfaction. In addition, the results of the research may contribute to the literature in terms of increasing evidence-based information on the use of the cold application in procedural pain and anxiety control in cancer patients.

02

Conditions studied

  • Pain
  • Anxiety

Browse trials for

Keywords

  • Cancer
  • Venous Port Catheter
  • Cold Therapy
  • Pain
  • Anxiety
03

In context

Anxiety Disorders

4,874 studies on the registry are indexed under Anxiety Disorders; 1,394 are open to participants now.

This study's enrollment of 112 is above the median of 80 across 4,180 interventional studies indexed under Anxiety Disorders.

Browse Anxiety Disorders studies →

Lead sponsor

Yuksek Ihtisas University is the lead sponsor of 21 studies on the registry; 3 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Clinical diagnosis of cancer disease
  • 18 years and over
  • no analgesic medication before three hours before the catheter removal procedure
  • conscious and cooperative
  • no communication problems
  • no visual no vision problems
  • with stable vital signs
  • without a diagnosis of anxiety disorder
  • volunteer participation

Exclusion criteria

Exclusion Criteria:

  • Body mass index less than 18.5
  • receiving Oxaliplatin infusions before venous port catheter removal
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
112 participants (actual)

Study arms

  • Experimental
    cold therapy

    Pain scores were measured with a visual analog scale (VAS) before the port catheter was removed from the patients in the experimental group. Before the port catheters were removed, cold application with an ice pack was applied to the patients whose first visual analog scale measurement was made by the researchers. The cold application was terminated an average of 15 minutes after the body temperature decreased by 1 °C.

    Other: cold therapy application

  • No intervention
    no intervention

    The patients in the control group did not receive any intervention before and after port catheter removal.

Interventions

  • Othercold therapy application

    cold therapy

06

What researchers measure

Primary outcomes

  1. Vertical Visual Analog Scale(VAS)

    Pain scores of the experimental and control groups were evaluated with VAS. The pain scores in both groups were shown to the patients by the researchers by showing the VAS, and they were asked to show at which point they experienced pain. The VAS scores of the patients in both groups were measured 10 minutes before the port catheter was removed (1st measurement), immediately after the catheter was removed (2nd measurement), and 10 minutes after the catheter was removed (3rd measurement). Pain intensity was measured by using a vertical visual analog scale(VAS) from "0 to 10", with high numbers meaning greater pain intensity. Iıt is indicated that compared with other tools, the vas is more sensitive and reliable in the measurement of pain intensity. Pain intensity can be categorized as mild (score, 1-3), moderate (score, 4-6), and severe (score, 7-10) according to the scale.

    Time frame: 20 minutes

Secondary outcomes

  1. The StateTrait Anxiety Inventory(STAI-I)

    The scores of the State-Trait Anxiety Inventory(STAI-I) Anxiety levels of the experimental and control groups were evaluated with STAI-I. The STAI-I scores of patients in both groups were measured 10 minutes before port catheter removal (1st measurement), and 10 minutes after catheter removal (2nd measurement). The patient's level of anxiety was evaluated by the State-Trait Anxiety Inventory(STAI-I.). While the first 20 items in the scale determine the state anxiety level, the second 20 items evaluate the trait anxiety level. The scores obtained from both scales theoretically vary between 20-80. In terms of anxiety levels in STAI-I, "0-19 points" from the scale, no anxiety, "20-39" points mild, "40-59" points moderate, "60-79" points severe, "80" score is evaluated as the level of panic and severe anxiety.

    Time frame: 20 minutes

07

Study locations

1 site
  • Arzu Bahar
    Ankara, Turkey
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 31, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05214703
Lead sponsor
Yuksek Ihtisas University
Responsible party
Arzu Bahar (assistant professor, Yuksek Ihtisas University) — Principal investigator
First posted
Jan 31, 2022
Start date
Feb 1, 2018
Primary completion
Jun 1, 2018
Completion
Sep 1, 2018
Last update
Jan 31, 2022

Study contacts

Arzu bahar, PhD
principal investigator · Yuksek Ihtisas University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion